Dynamine vs Caffeine: Onset, Duration, and What the Studies Show

Dynamine vs Caffeine: Onset, Duration, and What the Studies Show

Dynamine (methylliberine) is a fast-acting, short-lived purine alkaloid, while caffeine is the slower, longer-lasting stimulant you already know. The core pharmacokinetic difference: methylliberine reaches peak plasma concentration in about 36 to 54 minutes and clears with a half-life of 1.0 to 1.5 hours, versus caffeine's 5 to 6 hour half-life, both measured in the same 12 subjects (Mondal et al. 2022). They are not interchangeable. They do different things on different timelines.

Key Takeaways:

• Methylliberine peaks faster and leaves the body roughly 4x sooner than caffeine.
• In controlled testing, methylliberine alone did not raise blood pressure or heart rate; caffeine did.
• Methylliberine improved subjective mood, energy, and concentration but did not improve objective cognitive performance on standardized tests.
• The entire human evidence base for methylliberine is roughly 9 PubMed records, 5 of them human trials. The literature is small, and most of the positive studies were industry-funded.

How Do Dynamine and Caffeine Compare? The Numbers

The cleanest comparison comes from a single study where both compounds were measured in the same subjects under the same conditions. Mondal et al. (2022) ran a randomized, double-blind, crossover design with 24-hour blood sampling and UPLC-MS/MS quantification in 12 healthy adults. Here is what the tables show.

Sources: Pharmacokinetics from Mondal et al. 2022 (n=12). Blood pressure from Bloomer et al. 2020 (n=12). Mood and cognition from La Monica et al. 2023 (n=25). Safety from VanDusseldorp et al. 2020 (n=125). Caffeine Tmax and half-life are well-established reference values consistent with the Mondal dataset.

One thing the table makes clear: these are not the same molecule wearing different hats. They belong to different chemical subclasses entirely.

Is Dynamine Stronger Than Caffeine?

No. "Stronger" is the wrong frame. Methylliberine is faster and shorter, not more potent. Its plasma half-life of 1.0 to 1.5 hours means it is largely cleared from your system in the time it takes caffeine to reach its own peak effect.

This is consistent with what experienced users report. The common description is that methylliberine kicks in fast and fades fast, and that taken alone it feels subtle. It reads less like a standalone stimulant and more like a modifier, something that adds a front-loaded burst to a caffeine base. The pharmacokinetics predict this exactly: a compound that peaks in 36 to 54 minutes and halves in about an hour will feel brief.

Inside the coffee plant, caffeine is progressively converted into theacrine, then methylliberine, then liberine (Petermann and Baumann 1983). Methylliberine is literally a downstream metabolite of caffeine in Coffea species, specifically C. liberica, C. dewevrei, and C. abeokutae, where it appears occasionally in low concentrations. The commercial ingredient sold as Dynamine is synthetic, not a coffee extract. This matters because several competitor pages incorrectly source methylliberine to kucha tea. That is theacrine's origin, not methylliberine's.

Does Methylliberine Raise Blood Pressure the Way Caffeine Does?

This is the strongest honest differentiator between the two compounds, and it was tested within the same subjects.

Bloomer et al. (2020) measured heart rate, blood pressure, respiratory rate, and body temperature across six conditions in a Latin square design (n=12). Methylliberine alone did not raise any of these. All three caffeine-containing conditions raised both systolic and diastolic blood pressure.

That within-subject contrast is solid evidence. It was corroborated by Cintineo et al. (2022), a larger trial (n=48) funded by Compound Solutions whose authors reported no conflict of interest, which found that caffeine at 300 mg raised diastolic blood pressure versus placebo while a caffeine-plus-methylliberine-plus-theacrine arm did not. That study also showed both caffeine alone and the combined stack raised systolic blood pressure, so the picture is not completely clean for the combination.

The practical read: methylliberine on its own appears hemodynamically neutral at studied doses. Pair it with caffeine and you reintroduce caffeine's pressor effects, though possibly attenuated on the diastolic side. Do not interpret this as "Dynamine is safe for people with high blood pressure." No study tested that population.

Does Dynamine Actually Improve Focus?

Partially, and the distinction matters. La Monica et al. (2023) tested 100 mg of methylliberine against placebo in 25 healthy adults using a double-blind, randomized, crossover design. The paper's title tells you the result: "Methylliberine Ingestion Improves Various Indices of Affect but Not Cognitive Function in Healthy Men and Women."

What improved: subjective ratings of concentration, motivation, mood, energy, sustained energy, well-being, and ability to tolerate stress. What did not improve: objective cognitive performance on the Stroop test and Trail Making Test B. (For a fuller breakdown of these findings, see our methylliberine benefits and dosage guide.)

This is a genuine split. The compound made people feel more focused and energetic without measurably improving their performance on standardized cognitive tasks. That is worth knowing before you spend money on it. Many competitor pages cite only the positive half of this study. Reporting both halves is what separates useful information from marketing.

What the Evidence Does Not Show

Honesty about gaps is more useful than confidence without data to back it.

No evidence that methylliberine improves objective cognitive performance. The only study that tested it (La Monica 2023, n=25) found no improvement on Stroop or Trail Making B. This is a null result, not an ambiguous one.

No long-term safety data. The longest human safety study is VanDusseldorp et al. (2020), which followed 125 subjects over 4 weeks at 100 mg and 150 mg daily, alone and with theacrine. No clinically significant changes in blood biomarkers or cardiovascular function were observed. But 4 weeks is the ceiling. The preclinical toxicology package (Murbach 2019) was conducted in rats, not humans, and found no mutagenicity or genotoxicity. That is reassuring but not the same as multi-year human data. Both studies were funded by Compound Solutions, the patent holder of Dynamine, and this should factor into how you weight the results.

No head-to-head efficacy comparison with caffeine. The studies measured each compound's effects separately or in combination, but no trial randomized subjects to methylliberine versus caffeine on the same cognitive or performance outcome. The comparison table above stitches together separate study arms, which is the best available picture but not the same as a direct matchup.

The total literature is tiny. As of mid-2026, roughly 9 records exist in PubMed for methylliberine, with 5 of them being human trials. For caffeine, the number is in the tens of thousands. Treating these two evidence bases as equivalent would be misleading.

What This Means If You Are Choosing Between Them

The pharmacology suggests these compounds serve different roles rather than competing for the same one.

Caffeine is the proven cognitive enhancer. Decades of replicated research confirm it improves reaction time, vigilance, and sustained attention. Its drawback is the 5 to 6 hour half-life, which means a dose after early afternoon can push into your sleep window.

Methylliberine's 1 to 1.5 hour half-life makes it functionally the opposite. Users who take it in the late afternoon report that it does not disrupt sleep the way an equivalent caffeine dose would. That tracks with the pharmacokinetics. If you need a short burst of subjective alertness without committing to 6+ hours of stimulation, the duration profile fits.

The more interesting application, and the one the research actually supports, is pairing them. The Mondal et al. (2022) PK study found that co-administration of methylliberine with caffeine reduced caffeine's oral clearance from 41.9 to 17.1 L/hr and extended its half-life from 7.2 to 15 hours, with no increase in peak concentration. That arm used 100 mg methylliberine with 150 mg caffeine in 12 subjects. The mechanism appears to be CYP1A2 inhibition, which the study authors themselves frame as a drug-interaction signal, not purely a benefit. A longer caffeine half-life means more sustained effect, but it also means you need to be more careful about timing relative to sleep.

Neither compound replaces the other. The question is not "which one" but "what timeline do you need."

Different Tools, Not a Contest

Methylliberine and caffeine differ on three defensible axes: duration (1 to 1.5 hours vs 5 to 6 hours), cardiovascular impact (no observed pressor effect alone vs a measured blood pressure rise), and evidence depth (a handful of small, mostly industry-funded trials vs one of the largest pharmacological datasets in existence). Methylliberine is real, its effects are measurable, and its subjective benefits are supported. But it did not improve objective cognition in the only study that tested it, and its safety record does not extend past 4 weeks of human data. For a fast, short-acting subjective lift that pairs well with caffeine, the evidence is positive. For anything beyond that, the data simply is not there yet.

Frequently Asked Questions

Is Dynamine the same as caffeine?

No. Dynamine (methylliberine) is a methylurate, while caffeine is a methylxanthine. They are different chemical subclasses. Methylliberine reaches peak plasma concentration faster (about 36 to 54 minutes) and has a much shorter half-life of 1.0 to 1.5 hours, compared to caffeine's 5 to 6 hours. In the coffee plant, caffeine is actually converted into methylliberine through a biosynthetic pathway, but the commercial ingredient is synthetic.

Does Dynamine have side effects?

In controlled studies, methylliberine alone did not raise heart rate or blood pressure at doses up to 150 mg daily for 4 weeks (VanDusseldorp et al. 2020, n=125). No clinically significant changes in blood biomarkers were observed. That said, 4 weeks is the longest safety study available, and both existing safety studies were funded by the ingredient manufacturer. Long-term effects remain unstudied.

Can you take Dynamine and caffeine together?

Yes, and most commercial products pair them. Pharmacokinetic data from Mondal et al. (2022) shows that methylliberine slows caffeine's clearance, extending its half-life. This means the combination lasts longer than caffeine alone, but it also means you should be cautious about timing. Taking this combination late in the day could affect sleep more than caffeine alone would.

Is Dynamine a stimulant?

Methylliberine produces subjective feelings of energy and alertness without the cardiovascular stimulation seen with caffeine. It did not raise blood pressure or heart rate when tested alone. Whether that qualifies as a "stimulant" depends on your definition. It is not classified as a controlled substance and is sold as a dietary supplement ingredient.

How long does Dynamine last?

Based on its terminal half-life of 1.0 to 1.5 hours (Mondal et al. 2022, n=12), methylliberine is largely cleared within 3 to 5 hours. Users consistently describe its effects as fast-on, fast-off. This is roughly one-quarter the duration of caffeine's effects, making it better suited for short windows of focus or late-afternoon use where sleep disruption is a concern.

Does Dynamine build tolerance?

No study has tested whether methylliberine builds tolerance. The 4-week safety trial measured health markers, not habituation or efficacy over time. This is a gap in the literature. Do not confuse it with theacrine, which has specific (though limited) data suggesting reduced tolerance buildup compared to caffeine.

Where does methylliberine come from?

Methylliberine occurs naturally in Coffea species, specifically C. liberica, C. dewevrei, and C. abeokutae, where it appears in low concentrations as a metabolic intermediate between theacrine and liberine (Petermann and Baumann 1983). The commercial Dynamine ingredient is a pure, synthetic form, not a plant extract. Several sources incorrectly attribute it to kucha tea; that is theacrine, not methylliberine.

A Faster Onset and a Longer Tail, in One Pouch

The research on methylliberine and caffeine points to a clear pattern: they work best together, not as substitutes. Methylliberine provides a fast subjective lift within about 36 minutes. Caffeine provides the sustained cognitive drive. And when co-administered, methylliberine extends caffeine's effective window by slowing its clearance, though the study that demonstrated this (Mondal et al. 2022, n=12) used 100 mg methylliberine with 150 mg caffeine, so the magnitude of the effect at lower doses has not been directly measured.

Roon is built on this pairing. Each pouch combines caffeine, L-theanine, methylliberine (Dynamine), and theacrine (TeaCrine) in a sublingual format designed for a 5 to 10 minute onset and a 6 to 8 hour focus window. The methylliberine provides the fast front end; the caffeine-plus-theanine base provides the sustained middle; theacrine, which does not appear to build tolerance the way caffeine does, extends the tail.

Roon is not a methylliberine supplement on its own, and it is not a replacement for sleep, exercise, or medical treatment. It is a zero-sugar oral pouch that puts the combination the research actually supports into a format you can use without brewing, mixing, or swallowing capsules. If the pairing logic makes sense to you, try Roon and see if the felt experience matches the pharmacokinetics. Stop use at least 8 hours before bed.

Written by Roon Team